Malaysia-based hospital operator IHH Healthcare has reached out to its largest shareholder Mitsui & Co. to help open communication with Japanese drugmaker Daiichi Sankyo, even as both sides continue legal battles in India and Japan over damages worth about ₹11,800 crore.